All articles tagged with #mounjaro
The Independent explains that popular weight‑loss injections can have unwanted side effects and provides practical steps to manage them, including discussing dosing with a clinician, monitoring symptoms, and maintaining adequate nutrition to meet vitamin and mineral needs.
Health authorities warn about increased risks of suicidal thoughts and potential contraception failures associated with GLP-1 drugs like Ozempic and Mounjaro, which are used for diabetes and weight loss. While these drugs are generally effective, they may impact hormone absorption, reducing contraceptive efficacy, especially oral contraceptives. Patients should consult their doctors if experiencing mood changes or suicidal thoughts and consider alternative contraception methods if on GLP-1 medications. Use during pregnancy is not recommended due to potential risks.
President Trump is set to announce a deal aimed at lowering the prices of GLP-1 medications like Ozempic and Mounjaro, which he has previously highlighted as a key example in his efforts to reduce U.S. drug costs.
Groundbreaking diabetes and weight loss drugs like Ozempic, Mounjaro, and Wegovy offer significant benefits but vary greatly in cost worldwide, with the US being the most expensive and countries like India and the UK offering more affordable options. Patent expirations are expected to reduce prices further, potentially increasing access, but affordability remains dependent on local policies, insurance, and manufacturing factors.
Eli Lilly's obesity and diabetes drugs Mounjaro and Zepbound generated over $10 billion in Q3, fueling a booming market and a bidding war, with Novo Nordisk planning to acquire Metsera in a deal potentially worth up to $9 billion, highlighting intense competition in the GLP-1 receptor agonist space.
Eli Lilly's Q3 earnings surpassed expectations with $7.02 per share on $17.6 billion in sales, driven by strong sales of diabetes drug Mounjaro and weight-loss drug Zepbound, leading to an upward revision of annual guidance and a 3.9% rise in stock price.
Eli Lilly exceeded earnings and revenue estimates in Q3, driven by strong sales of weight loss drug Zepbound and diabetes treatment Mounjaro, leading to an upward revision of its full-year outlook and a 5% premarket stock increase.
Amy Schumer shared an unfiltered selfie on Instagram, highlighting her body post-Mounjaro, a drug she praised for weight loss after previous negative experiences with Ozempic, emphasizing body positivity and transparency.
Amy Schumer shared her dramatic weight loss after using the GLP-1 medication Mounjaro, following her previous experience with Ozempic, and received praise from fans and friends on Instagram.
Amy Schumer responded positively to comments about her legs after sharing a photo from her trip to Las Vegas, where she was praised by celebrities for her appearance. She also shared her experience with weight loss drugs, noting a better experience with Mounjaro compared to Ozempic.
Amy Schumer showcased her significant weight loss in a recent Instagram post, sharing her journey with medications like Ozempic and Mounjaro, and emphasizing her commitment to transparency about her health and weight loss methods.
Meghan Trainor showcased her significant weight loss and new look at the premiere of 'The Paper,' revealing she used a weight-loss drug called Mounjaro, along with lifestyle changes and a breast lift, to achieve her transformation, which has garnered both praise and criticism.
Hope Lancaster Colquhoun lost nine stone using Mounjaro, but experienced severe dental side effects, including tooth loss, which are increasingly reported among users of GLP-1 drugs. Experts link these issues to acid reflux, dry mouth, and nutritional deficiencies caused by rapid weight loss and medication effects, raising concerns about the safety of these weight loss treatments.
Eli Lilly is increasing the price of its weight-loss drug Mounjaro in the UK by 170% to align global prices and reduce disparities with US prices, amid political pressure from the Trump administration to lower US drug costs. The price hike aims to balance contributions to innovation costs across countries, while NHS access remains unchanged.
Eli Lilly announced a significant price increase of up to 170% for its drug Mounjaro in the UK, responding to U.S. government pressure to align drug prices globally, amid ongoing debates over drug pricing policies and their impact on stock performance.